Medtronic PLC (MDT)
Industry Medical Devices
This stock can be held in an Investment ISA and an Investment Account
Sell
$85.89
Buy
$87.00
$-0.65 (-0.74%)
Prices updated at 28 Mar 2025, 08:20 EDT
| Prices minimum 15 mins delay
Prices in USD
Medtronic PLC is a medical technology company. It primarily manufacture and sell device-based medical therapies. It operates in Cardiac and Vascular, Minimally Invasive Therapies, Restorative Therapies and Diabetes segments.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2023 | 2024 |
|---|---|---|
| 31,227m | 32,364m | |
| 20,508m | 21,148m | |
| 5,830m | 5,520m | |
| 18.67 | 17.06 | |
| 3,758m | 3,676m | |
| 8,697m | 8,203m | |
| Sales, General and administrative | 10,415m | 10,736m |
| Interest expenses | 636m | 719m |
| Provision for income taxes | 1,580m | 1,133m |
| Operating expenses | 14,678m | 15,628m |
| Income before taxes | 5,364m | 4,837m |
| Net income available to common shareholders | 3,758m | 3,676m |
| 3.09 | 3.28 | |
| Net interest income | -636m | -719m |
| Advertising and promotion | - | - |
| Net investment income, net | - | - |
| Realised capital gains (losses), net | - | - |
| Total benefits, claims and expenses | - | - |
| Earnings per share (diluted) | 3.08 | 3.27 |
| Free cash flow per share | 3.0355 | 4.1975 |
| Book value/share | 38.7018 | 37.8184 |
| Debt equity ratio | 0.472855 | 0.4766 |
Balance sheet
Year | 2023 | 2024 |
|---|---|---|
| Current assets | 21,675m | 21,935m |
| Current liabilities | 9,051m | 10,789m |
| Total capital | 75,770m | 74,091m |
| Total debt | 24,364m | 25,024m |
| Total equity | 51,483m | 50,214m |
| Total non current liabilities | - | - |
| Loans | 24,287m | 23,877m |
| Total assets | 90,948m | 89,981m |
| Total liabilities | - | - |
| Cash and cash equivalents | 1,543m | 1,284m |
| Common stock | 1,331m | 1,311m |
Cash flow
Year | 2023 | 2024 |
|---|---|---|
| Cash at beginning of period | 3,714m | 1,543m |
| Cash dividends paid | -3,616m | -3,666m |
| 4,580m | 5,200m | |
| Investments (gains) losses | -3,493m | -2,366m |
| 1,543m | 1,284m | |
| Net income | - | - |
| 6,039m | 6,787m | |
| -1,459m | -1,587m |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.
